Experts are gettling closer to tests that will distinguish dangerous prostate cancer tumors from harmlesss tumors, and may eventually save tens of thousands of men from unnecessary treatment that could leave them incontinent and impotent. US News & World Report reports that researchers at the Dana-Farber Cancer Center in Boston have found that the combined activity of four genes appeared to be associated with deadly prostate tumors. The new method of diagnosis of life-threatening prostate cancer was 91 percent accurate when the experimental gene test was used with the standard combination of current indicators: age at diagnosis; indications of tumor spread; and an assessment of tumor cells under a microscope (Gleason score). This compares to an accuracy of 84 percent for the standard approach alone. The research was published in Nature. The Wall Street Journal reports that a genetic test based on the findings is being developed and could be available within a couple of years. Read more on the research from Reuters.
Health, fitness and lifestyle tips for people over 50 who still like to play hard
Sunday, June 1, 2025
This is good news. At least. there are some more studies and research being done for men suffering prostate cancer. Thanks for the link. I am really interested to hear some findings about researches and treatments for cancers.